AMT medical
Jorrit Kelderman currently serves as COO/CFO at AMT Medical since August 2023 and has held various advisory roles with Pacmed and Techleapnl from 2022 to 2024. Prior experience includes CFO positions at ViCentra (2018-2022), NightBalance (2016-2018), and Qardio, Inc. (2014-2016), along with a sabbatical as an advisor at Kelderman Advies en Interim Management in 2014. Jorrit's earlier roles encompass director and head of finance positions at RWE and Essent, as well as being an investment banking analyst at J.P. Morgan. Jorrit holds a degree in Financial Economics from Vrije Universiteit Amsterdam and an Executive Master in the Register Controllers programme from Nyenrode Business University, supplemented by a Post Graduate scholarship at Leiden University.
This person is not in any teams
This person is not in any offices
AMT medical
AMT Medical BV has developed a minimal invasive medical device for heart bypass surgery. The AMT Heart Bypass System is based on the ELANA bypass, technology invented by neurosurgeon Prof. Dr. C.A.F. Tulleken and his research team of the UMCU. The technique is designed to make the traditional heart bypass procedures faster, safer, easier and lessinvasive for the patient.The product has been fully developed, production process has been designed, all pre-clinical trials have finished, a clinical multi-center trial will commence late 2019, early 2020.